1-6 of 6
Monika Motyckova
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Comorbidities and Concomitant Medications on Survival of Patients with Chronic Lymphocytic Leukemia: Analysis of an Unselected Patient Population from East Bohemia

Free
Pavel Vodarek, MD, Denisa Zeberova, Martin Simkovic, MD PhD, Monika Motyckova, MD PhD, David Belada, MD PhD, Pavel Žák, MD PhD, Lukas Smolej, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5328.
https://doi.org/10.1182/blood.V130.Suppl_1.5328.5328
Published: 2017
Journal Articles

Stem Cell Mobilization after Various Induction Regimens in Patients with Multiple Myeloma

Free
Jakub Radocha, MD PhD, Vladimir Maisnar, MD PhD, Miriam Lanska, MD, Jiri Hanousek, MD, Katerina Machalkova, MD, Katerina Beranova, MD, Alzbeta Zavrelova, MD, Monika Motyckova, MD PhD, Pavel Zak, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5433.
https://doi.org/10.1182/blood.V126.23.5433.5433
Published: 2015
Journal Articles

Low-Dose FCR Is a Safe and Effective Treatment Option for Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Updated Results of Project Q-Lite By Czech CLL Study Group

Free
Lukas Smolej, MDPhD, Yvona Brychtova, MD PhD, Michael Doubek, Prof., MD PhD, Eduard Cmunt, MDPhD, Martin Spacek, MD, PhD, David Belada, MD, Monika Motyckova, MDPhD, Irena Zygulova, MD, Dagmar Adamova, MD, Vit Prochazka, MDPhD, Martin Simkovic, MD, Katerina Klaskova, MS, Tomas Kozak, MDPhD
Journal: Blood
Blood (2014) 124 (21): 4670.
https://doi.org/10.1182/blood.V124.21.4670.4670
Published: 2014
Journal Articles

Rituximab and High-Dose Dexamethasone (R-dex) Is Effective In The Treatment Of Relapsed/Refractory Chronic Lymphocytic Leukemia

Free
Martin Simkovic, M.D., David Belada, M.D., Ph.D., Monika Motyckova, M.D., Lukas Smolej, MD, PhD, Pavel Zak, Assoc. Prof., MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4184.
https://doi.org/10.1182/blood.V122.21.4184.4184
Published: 2013
Journal Articles

The Fate of Chronic Lymphocytic Leukemia Patients After Failure of Fludarabine, Cyclophosphamide, and Rituximab Regimen

Free
Anna Panovska, MD, Daniel Lysák, MD, Lukas Smolej, M.D., Ph.D., Yvona Brychtova, M.D., Ph.D., Martin Simkovic, MD, Monika Motyckova, M.D., Michaela Lindtnerova, MD, Martin Trbusek, PhD, Jitka Malcikova, Dr, PhD, Sarka Pospisilova, Prof., Jiri Mayer, M.D., PhD., Prof., Michael Doubek, M.D., PhD., Prof.
Journal: Blood
Blood (2012) 120 (21): 4603.
https://doi.org/10.1182/blood.V120.21.4603.4603
Published: 2012
Journal Articles

Low-Dose Fludarabine and Cyclophosphamide Combined with Rituximab In the Treatment of Elderly/Comorbid Patients with chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Preliminary Results of Project Q-Lite by Czech CLL Study Group

Free
Lukas Smolej, M.D., Ph.D., Martin Spacek, M.D., Yvona Brychtova, MD, David Belada, M.D., Ph.D., Jiri Schwarz, M.D., Ph.D., Michael Doubek, MD, PhD, Monika Motyckova, M.D., Eduard Cmunt, M.D., Ph.D., Peter Rohon, MD, Katerina Klaskova, M.S., Tomas Kozak, M.D., Ph.D.
Journal: Blood
Blood (2010) 116 (21): 2466.
https://doi.org/10.1182/blood.V116.21.2466.2466
Published: 2010